These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever. Maarbjerg SF, Thorsted A, Friberg LE, Nielsen EI, Wang M, Schrøder H, Albertsen BK. Cancer Rep (Hoboken); 2022 Oct; 5(10):e1585. PubMed ID: 34796702 [Abstract] [Full Text] [Related]
7. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus. Salvador E, Oualha M, Bille E, Beranger A, Moulin F, Benaboud S, Boujaafar S, Gana I, Urien S, Zheng Y, Toubiana J, Briand C, Bustarret O, Geslain G, Renolleau S, Treluyer JM, Hirt D. Clin Microbiol Infect; 2021 Mar; 27(3):413-419. PubMed ID: 32360445 [Abstract] [Full Text] [Related]
8. Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen. Thorsted A, Kristoffersson AN, Maarbjerg SF, Schrøder H, Wang M, Brock B, Nielsen EI, Friberg LE. J Antimicrob Chemother; 2019 Oct 01; 74(10):2984-2993. PubMed ID: 31273375 [Abstract] [Full Text] [Related]
18. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients. Dhaese SAM, Roberts JA, Carlier M, Verstraete AG, Stove V, De Waele JJ. Int J Antimicrob Agents; 2018 Apr 01; 51(4):594-600. PubMed ID: 29277531 [Abstract] [Full Text] [Related]